{"id":58804,"date":"2024-01-30T22:04:43","date_gmt":"2024-01-30T21:04:43","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\/"},"modified":"2024-01-30T22:04:43","modified_gmt":"2024-01-30T21:04:43","slug":"inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\/","title":{"rendered":"Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024"},"content":{"rendered":"
\n

GOLETA, Calif.–(BUSINESS WIRE)–Inogen, Inc.<\/a> (Nasdaq: INGN<\/a>), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report fourth quarter and full year 2023 financial results after the market closes on Tuesday, February 27, 2024. On the same day, the Company will host a conference call at 2:00 p.m. PT \/ 5:00 p.m. ET.<\/p>\n

<\/a>
<\/a><\/p>\n

\nIndividuals interested in listening to the conference call may do so by dialing:<\/p>\n

\nUS domestic callers (877) 841-3961
\n
Non-US callers (201) 689-8589<\/p>\n

\nPlease reference Inogen to join the call. To listen to a live webcast, please visit the Investor Relations section of Inogen’s website at: http:\/\/investor.inogen.com\/<\/a>. This webcast will also be archived on the website for 6 months.<\/p>\n

\nA replay of the call will be available approximately three hours after the live webcast ends and will be accessible through March 5, 2024. To access the replay, dial (877) 660-6853 or (201) 612-7415 and reference Conference ID: 13743411.<\/p>\n

\nInogen has used, and intends to continue to use, its Investor Relations website, http:\/\/investor.inogen.com\/<\/a>, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http:\/\/investor.inogen.com\/<\/a>.<\/p>\n

\nAbout Inogen<\/b><\/p>\n

\nInogen, Inc. (Nasdaq: INGN) is a leading global medical technology company offering innovative respiratory products for use in the homecare setting. Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Inogen partners with patients, prescribers, home medical equipment providers, and distributors to make its oxygen therapy products widely available allowing patients the chance to remain ambulatory while managing the impact of their disease.<\/p>\n

\nFor more information, please visit www.inogen.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nir@inogen.net<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

GOLETA, Calif.–(BUSINESS WIRE)–Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report fourth quarter and full year 2023 financial results after the market closes on Tuesday, February 27, 2024. On the same day, the Company will host a conference call at … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-58804","6":"format-standard","7":"category-industry"},"yoast_head":"\nInogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"GOLETA, Calif.–(BUSINESS WIRE)–Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report fourth quarter and full year 2023 financial results after the market closes on Tuesday, February 27, 2024. On the same day, the Company will host a conference call at ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-30T21:04:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240130019757\/en\/622619\/21\/Inogen_Logo_300_DPI.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024\",\"datePublished\":\"2024-01-30T21:04:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\\\/\"},\"wordCount\":306,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240130019757\\\/en\\\/622619\\\/21\\\/Inogen_Logo_300_DPI.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\\\/\",\"name\":\"Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240130019757\\\/en\\\/622619\\\/21\\\/Inogen_Logo_300_DPI.jpg\",\"datePublished\":\"2024-01-30T21:04:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240130019757\\\/en\\\/622619\\\/21\\\/Inogen_Logo_300_DPI.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240130019757\\\/en\\\/622619\\\/21\\\/Inogen_Logo_300_DPI.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\/","og_locale":"en_US","og_type":"article","og_title":"Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 - Pharma Trend","og_description":"GOLETA, Calif.–(BUSINESS WIRE)–Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report fourth quarter and full year 2023 financial results after the market closes on Tuesday, February 27, 2024. On the same day, the Company will host a conference call at ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\/","og_site_name":"Pharma Trend","article_published_time":"2024-01-30T21:04:43+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240130019757\/en\/622619\/21\/Inogen_Logo_300_DPI.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024","datePublished":"2024-01-30T21:04:43+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\/"},"wordCount":306,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240130019757\/en\/622619\/21\/Inogen_Logo_300_DPI.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\/","url":"https:\/\/pharma-trend.com\/en\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\/","name":"Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240130019757\/en\/622619\/21\/Inogen_Logo_300_DPI.jpg","datePublished":"2024-01-30T21:04:43+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240130019757\/en\/622619\/21\/Inogen_Logo_300_DPI.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240130019757\/en\/622619\/21\/Inogen_Logo_300_DPI.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/inogen-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-27-2024\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58804","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=58804"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58804\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=58804"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=58804"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=58804"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}